Carter Robert Ross — SEC insider filings
SEC reporting owner CIK 2039341. 13 insider filings on record with FilingPulse; latest filed 2026-11-19.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-11-21 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 9,056 shares, $9,434 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 247 shares, $879 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 9,056 shares @ $1.04 ($9,434) in Starling Oncology, Inc., filed 2025-03-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Starling Oncology, Inc. (STLN) | Chief Financial Officer | 13 | 1 leg · 9,056 sh · $9,434 | 1 leg · 247 sh · $879 | 13 |
Insider filings — Carter Robert Ross
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | Starling Oncology, Inc. (STLN) | Other (J): 138 @ $3.40 | EDGAR |
| 2026-05-22 | 4 | Oncology Institute, Inc. (TOI) | Other (J): 1,604 @ $4.47 | EDGAR |
| 2026-04-01 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 202,914 @ $0 · Other (J): 20,320 @ $3.07 | EDGAR |
| 2026-03-18 | 4 | Oncology Institute, Inc. (TOI) | Other (J): 1,314 @ $3.59 | EDGAR |
| 2026-01-06 | 4/A | Oncology Institute, Inc. (TOI) | Other (J): 244 @ $3.67 | EDGAR |
| 2026-01-05 | 4 | Oncology Institute, Inc. (TOI) | Sale (S): 247 @ $3.56 | EDGAR |
| 2025-11-19 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 195 @ $0 | EDGAR |
| 2025-05-22 | 4 | Oncology Institute, Inc. (TOI) | Disposition to issuer (D): 1,601 @ $2.67 | EDGAR |
| 2025-04-02 | 4 | Oncology Institute, Inc. (TOI) | Grant/award (A): 197,368 @ $0 | EDGAR |
| 2025-03-28 | 4 | Oncology Institute, Inc. (TOI) | Purchase (P): 9,056 @ $1.04 · Purchase (P): 4,528 (derivative) @ $0.12 | EDGAR |
| 2025-03-20 | 4 | Oncology Institute, Inc. (TOI) | Disposition to issuer (D): 1,150 @ $0.89 | EDGAR |
| 2025-01-07 | 4 | Oncology Institute, Inc. (TOI) | Disposition to issuer (D): 258 @ $0.34 | EDGAR |
| 2024-11-21 | 4 | Oncology Institute, Inc. (TOI) | Disposition to issuer (D): 235 @ $0.14 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2039341 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs